bioscience editing solutions LLC

909 3rd ave. #6203
new york, new york 10150

NYS Entity Status
ACTIVE

NYS Filing Date
JANUARY 23, 2014

NYS DOS ID#
4517783

County
NEW YORK

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2014 - BIOSCIENCE EDITING SOLUTIONS LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Alexandria Debuts NY’s Latest Bio Incubator With 13 Startups in Tow
    By Ben Fidler - Tuesday Jun 13, 2017

    A new startup incubator has just opened in Manhattan this morning, adding to a growing list of facilities meant to help support seedling New York City biotechs. LaunchLabs, first announced by Alexandria Real Estate Equities a year ago, officially opened its doors and revealed the 13 startups that will grow there. LaunchLabs is a 15,000-square-foot […]

    Source: Xconomy New York
  • Fit City: Taking Night-Life Cue, Gyms Lower the Lights
    By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017

    Cycling, boxing and running studios, as well as some full-service gyms, are using sophisticated lighting systems to heighten the exercise experience.

    Source: NYT > Home Page
  • Conviction Overturned for ex-NY Assembly Speaker Sheldon Silver
    Thursday Jul 13, 2017

    A federal appeals court has overturned the corruption conviction of former New York Assembly Speaker Sheldon Silver.

    Source: NBC News
  • Coffee recalled for containing Viagra-like ingredient
    By Fox News - Thursday Jul 20, 2017

    A company based in Texas has recalled a coffee product after a substance found in a drug used to treat erectile dysfunction was found in the product, the Food and Drug Administration (FDA) confirmed. Bestherbs Coffee LLC has recalled all of its “New of Kopi Jantan Tradisional Herbs Coffee” after the FDA said it found...

    Source: New York Post: News
  • Bio Roundup: PDUFA Progress, BCRA Redux, CAR-T Thumbs Up, & More
    By Frank Vinluan - Friday Jul 14, 2017

    Government and industry are rife with awkward acronyms. Take PDUFA, for example. First passed in 1992, the Prescription Drug User Fee Act allows the FDA to collect fees from biopharmaceutical companies when they apply for drug approval; those funds are designated for the regulator’s drug evaluation work. Congress must reauthorize the law every five years […]

    Source: Xconomy New York
bioscience editing solutions llc new york ny